SALISBURY HOUSE, LLC – Trademark Portfolio
Entity Type: 16
SALISBURY HOUSE, LLC holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 45 (Legal & Security Services) — 6 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 8 trademarks are registered. Notable registered marks include NEW STORY, YOUR LIFE ABA, and NEW STORY SCHOOLS. The owner is based in BALTIMORE, MD.
2 VILLAGE SQUARE
BALTIMORE, MD 21210
Showing of trademarks Trademarks
Trademark Classifications
SALISBURY HOUSE, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Legal services; security services for the protection of property and individuals
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does SALISBURY HOUSE, LLC have?
SALISBURY HOUSE, LLC has 8 U.S. trademarks filed with the USPTO. Of these, 8 registered.
What trademark classes does SALISBURY HOUSE, LLC file in?
SALISBURY HOUSE, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 45 (Legal & Security Services), Class 44 (Medical Services), Class 41 (Education & Entertainment). Class 45 covers legal services; security services for the protection of property and individuals.
What are SALISBURY HOUSE, LLC's most well-known trademarks?
SALISBURY HOUSE, LLC's registered trademark portfolio includes well-known marks such as NEW STORY, YOUR LIFE ABA, and NEW STORY SCHOOLS. These are among 8 currently registered trademarks in the portfolio.
What is SALISBURY HOUSE, LLC's trademark registration success rate?
SALISBURY HOUSE, LLC has a 100% trademark registration rate, with 8 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.